Please use this identifier to cite or link to this item:
Title: Benefits and harm of systemic steroids for short- And long-term use in rhinitis and rhinosinusitis: an EAACI position paper
Author: Hox, Valerie
Lourijsen, Evelijn
Jordens, Arnout
Aasbjerg, Kristian
Agache, Ioana
Alobid, Isam
Bachert, Claus
Boussery, Koen
Campo, Paloma
Fokkens, Wytske
Hellings, Peter
Hopkins, Claire
Klimek, Ludger
Mäkelä, Mika
Mösges, Ralph
Mullol i Miret, Joaquim
Pujols Tarrés, Laura
Rondon, Carmen
Rudenko, Michael
Toppila‑Salmi, Sanna
Scadding, Glenis
Scheire, Sophie
Tomazic, Peter‑Valentin
Van Zele, Thibaut
Wagemann, Martin
van Boven, Job F. M.
Gevaert, Philippe
Keywords: Rinitis
Issue Date: 3-Jan-2020
Publisher: BioMed Central
Abstract: Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that - potentially severe - side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.
Note: Reproducció del document publicat a:
It is part of: Clinical and Translational Allergy, 2020, vol. 10
Related resource:
ISSN: 2045-7022
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
12474_6016514_13601_2019_article_303.pdf1.17 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons